Pharmapack Europe Launches Start-up Hub
The Start-up Hub is designed to give start-up companies the opportunity to network at Pharmapack.
On May 31, 2016 Pharmapack Europe announced the launch of its Start-up Hub, a new addition to the 2017 event at the Paris Expo Porte de Versailles from February 1-2, 2017. According to Pharmapack, the Start-up Hub is a platform designed to give young pharmaceutical firms the ability to network at the conference for an affordable price. Companies at the Start-up Hub will have the opportunity to showcase ideas, meet potential customers, partners and investors, and forge new relationships.
According to Pharmapack, there are only ten spots available for companies in the Start-up Hub. Exhibitors will be selected by Pharmapack’s advisory board of industry experts. The board will fill available spots based on the uniqueness, market prospects, patient impact, and savings potential of each company’s innovations, Pharmapack said in a press announcement. Firms pursuing all types of pharma and biopharma packaging innovation are encouraged to apply. Entry closes on July 28, 2016 and recipients will be announced in early September.
Source: Pharmapack Europe
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
